What Anziam Bio does
Founded in 2020, Anziam Bio operates in Health Tech offering advanced wound care solutions that are clinically proven for the management of acute and chronic wounds. The company's portfolio addresses wounds resulting from conditions such as diabetes, immobility, and venous disease, as well as injuries from traumatic incidents, burns, and invasive surgery. Anziam Bio aims to make these advanced Med-tech solutions accessible to a wider population.
Who runs it
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Anziam Bio yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.